Navigation Links
Genetic defects give the immune system the green light to attack the pancreas

Scientists at Joslin Diabetes Center have found genetic regions that, when defective, allow the immune system to attack the pancreas ?the first in a series of mis-steps that lead to type 1 diabetes. Armed with these findings published March 22 in the journal Immunity, the researchers are now trying to hone in on the exact genes involved, in mice and in human patients.

“The significance of this study is that we found the chromosomal regions involved and can now zero in on the precise genes,?said Diane Mathis, Ph.D., the study’s principal investigator along with Christophe Benoist, M.D., Ph.D. They head the Section on Immunology and Immunogenetics at Joslin, and hold joint William T. Young Chairs in Diabetes Research. They are also Professors of Medicine at Harvard Medical School. The work was spearheaded by a group of Joslin fellows, hailing from across the globe: Silvia Zucchelli, Ph.D., who has now returned to Italy; Phil Holler, Ph.D., from the U.S.; and Tetsuya Yamagata, M.D., Ph.D, from Japan.

The genetic defect keeps the body from properly dealing with “errant?immune cells that it normally eliminates by a process called immunological tolerance. These immune cells then attack the insulin-producing beta cells in the pancreas, mistaking them as foreign invaders. “It’s critical for the immune system to recognize and tolerate tissues that belong in the body, which immunologists call ‘tolerance,’?said Dr. Zucchelli. “Previous studies have shown that when the T-cells don’t learn this tolerance, they can infiltrate the pancreas and attack the insulin-producing beta cells.?This first step in the onset of type 1 diabetes is called insulitis. Later in life, within weeks or even years, full-blown type 1 diabetes emerges.

An estimated 1 million people in the United States have type 1 diabetes. Their pancreatic beta cells can no longer make insulin. Without this crucial hormone, their body cannot convert food into energy. To sustain life, they must get insulin through injections. The disorder can emerge in childhood, adolescence and even appear in adulthood, but the genetic stage is set beforehand.

T-cells play a key role. They are part of the highly complex array of immune cells that normally work together to fight invaders such as bacteria or viruses, adapting specifically to each new invader. Formed in the thymus gland, T-cells begin as “precursor?cells and mature ?during this time, receptor sites on their outer membrane are shaped to dock with each invader and destroy it.

“As T-cells form, it is not uncommon for a few to randomly develop with the potential ability to attack the body’s own cells,?said Dr. Holler. “That’s when a safeguard mechanism normally kicks in to eliminate these errant T-cells. Our team found the genetic regions that govern this safeguard.?/p>

What if the safeguard mechanism is defective? Left unchecked, the self-destructive T-cells can roam throughout the body and wreak havoc. This is the process behind many autoimmune, or “self-immune,?diseases such as type 1 diabetes, multiple sclerosis, rheumatoid arthritis and others.

To understand what happens in type 1 diabetes, the researchers combined a unique set of cutting-edge technologies, using cultures of thymus cells from transgenic mice, together with DNA chips and “genome scans.?They compared non-obese diabetic (NOD) mice, which researchers elsewhere had shown to have the tolerance defect, with diabetes-resistant controls. They looked for regions where the data from the DNA chips and the genome scan converged. Overlap would indicate the regions and genes that affect tolerance.

In the mice with diabetes, two findings emerged ?a distinct decrease of activity in regions that governed the elimination of errant T-cells, and an increase of activity promoting their survival. The safeguard system was broken. The T-cells were alive and able to leave the thymus and attack beta cells.

Now that the chromos omal regions are known, the researchers are seeking the precise genes involved. “Once these genes are identified, we will be better able to define the biologic pathways that lead to type 1 diabetes,?said Dr. Yamagata. “We then can work on designing ways to subdue or stop this process.?/p>

This study was supported by the Juvenile Diabetes Research Foundation (JDRF), in the context of the JDRF Center on Immunological Tolerance in Type-1 Diabetes at Harvard Medical School.


'"/>

Source:Joslin Diabetes Center


Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Genetically modified natural killer immune cells attack, kill leukemia cells
3. Ants Genetic Engineering Leads To Species Interdependency
4. Genetic Variation Visualization - From EMBL
5. Genetically modified rice in China benefits farmers health, study finds
6. Infants With Rare Genetic Disease Saved by Cord Blood Stem Cells
7. Genetically Modified Natural Killer Immune Cells Attack, Kill Leukemia Cells
8. Maine Researchers Find Exceptions to Old Rules of Genetic Inheritance
9. Genetic therapy reverses nervous system damage in animal model of inherited human disease
10. Infants with Rare Genetic Disease Saved By Cord Blood Stem Cells
11. Researchers Find New Technique To Identify Fetal Genetic Material From Amniotic Fluid
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/3/2017)... 3, 2017 A new independent identity strategy ... LLP (IdSP) . Designed to fill a critical niche ... market, founding partners Mark Crego and ... just in identity expertise that span federal governments, the ... The Crego-Kephart combined expertise has a common theme born ...
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
(Date:1/24/2017)... Jan. 24, 2017 Biopharm Reports has ... laboratory use of nuclear magnetic resonance spectroscopy (NMR). ... and profiled current practices, developments, trends and end-user ... as growth and opportunities. These areas include growth ... instruments, needs and innovation requirements, hyphenated NMR techniques, ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... Feb. 23, 2017 China Biologic Products, Inc. (NASDAQ: ... plasma-based biopharmaceutical company in China, today announced its financial results ... Fourth Quarter 2016 Financial Highlights ... by 21.7% in RMB terms, or increased by 13.6% in ... same quarter of 2015. Gross profit increased ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... Services portfolio to include an array of biochemical analyses critical for Lead ... to drive their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism ...
(Date:2/23/2017)... 23, 2017  Imanis Life Sciences announced today ... oncolytic vaccinia viruses for virotherapy research. These viruses ... Genelux,s proprietary, vaccinia virus-based technology platform for research ... into a partnership with Genelux to offer researchers, ... for use in research," said Dr. Kah ...
(Date:2/23/2017)... Winston-Salem, NC (PRWEB) , ... February 23, 2017 , ... ... pleased to announce a new partnership with Compass Research . GGI's mission is ... gifting a vaccine to a child in need in honor of each clinical trial ...
Breaking Biology Technology: